Newsroom
March 13, 2023
Mays Cancer Center at UT Health San Antonio melanoma expert Monte Shaheen, MD, was part of a team of investigators that conducted a phase II clinical trial to determine the efficacy and safety of administering the immunotherapy drug pembrolizumab before and after surgery in high-risk melanoma patients.
February 22, 2023
In a new study, researchers from UT Health San Antonio link obesity with 21 Alzheimer’s disease-related genes, providing a potential explanation for why Alzheimer’s is sometimes more frequent among adults who experienced obesity in midlife.
February 22, 2023
Obesity in midlife and in women most closely linked to dementia Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (Feb. 22, 2023) — In a new study, researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) link obesity with 21 Alzheimer’s disease-related genes, providing a potential mechanistic explanation for […]
January 5, 2023
Researchers report treatment for combat-related post-traumatic stress disorder, which affects hundreds of thousands of U.S. military personnel and veterans, can be both fast and effective for a majority of patients.
August 23, 2022
UT Health San Antonio is investing $5 million over the next three years in cryo-electron microscopy (cryo-EM for short). The state-of-the-art technology adds a powerful new tool to solve disease riddles at the molecular level.
June 27, 2022
The Dialysis Doggos are part of a research study being conducted by Meredith L. Stensland, PhD, LMSW, assistant professor of research in the Department of Psychiatry and Behavioral Sciences. The study investigates the effect of an animal assisted intervention for patients receiving dialysis, and if this intervention improves symptoms of pain and depression and reduces the number of skipped dialysis treatment sessions.
